Clinical Trial Update: A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968 [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports the completion of a single-dose study of LEO 158968 evaluating efficacy, safety, tolerability, pharmacokinetics, and pharmacod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthralgia
• Arthritis
• Gout

Drugs mentioned

• LEO 158968

Snippet

Sponsor: LEO Pharma | Conditions: Joint Pain, Gout Flares | Phase 1 | Status: COMPLETED